Molecular Docking and Dynamics Investigations for Identifying Potential Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2: Repurposing of Approved Pyrimidonic Pharmaceuticals for COVID-19 Treatment

This study demonstrates the inhibitory effect of 42 pyrimidonic pharmaceuticals (PPs) on the 3-chymotrypsin-like protease of SARS-CoV-2 (3CL(pro)) through molecular docking, molecular dynamics simulations, and free binding energies by means of molecular mechanics–Poisson Boltzmann surface area (MM-P...

Descripción completa

Detalles Bibliográficos
Autor principal: Elzupir, Amin Osman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707611/
https://www.ncbi.nlm.nih.gov/pubmed/34946540
http://dx.doi.org/10.3390/molecules26247458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707611/
https://www.ncbi.nlm.nih.gov/pubmed/34946540
http://dx.doi.org/10.3390/molecules26247458

Ejemplares similares